Erweiterte Suche
Wertpapiere
Name | Mnemo | Börse | Durchschn. Volumen | Kurs | Typ | |
---|---|---|---|---|---|---|
LUIGI BOTTO | MLLB | Euronext Paris | 0 | 0,5 EUR | Aktie |
Nachrichten (75)
Insiders
Derzeit hat Luigi Lovaglio die Position des Chief Executive Officer & General Manager der Credito Valtellinese SpA inne. In der Vergangenheit bekleidete er die Position des President-Management Board & CEO bei BANK POLSKA KASA OPIEKI SA und Executive Director & Deputy Chairman bei UniCredit Bulbank AD. Luigi Lovaglio erwarb einen Bachelor-Abschluss an der Universität von Bologna.
Vincent Lovaglio is an Analyst at Corbets Capital since 2023.
Prior to this, he worked as a Vice President at Mizuho Securities USA LLC from 2018 to 2023, an Equity Research Associate at Wolfe Research LLC from 2014 to 2018, an Equity Analyst at SG Americas Securities LLC in 2013, an Associate at Cowen Securities LLC in 2013, and an Associate at Dahlman Rose & Co. LLC from 2012 to 2013.
He completed his undergraduate degree from The Trustees of Columbia University in The City of New York in 2012.
Luigi Costa is the founder of Noema Pharma AG.
He currently serves as the Chairman of PinCell Srl.
Previously, he served as the Chief Executive Officer of Nordic Nanovector ASA from 2014 to 2018.
He also held managing director positions at Amgen Dompé SpA and Amgen SAS, and was the Head-International Oncology Franchise at Amgen, Inc. Additionally, he served as the Vice President-Europe, Middle East & Africa Region at Onyx Pharmaceuticals, Inc. Mr. Costa received his undergraduate degree from the University of Parma and his MBA from SDA Bocconi School of Management.
Luigi Avagliano is currently the Managing Director at Fata Vita SpA.
Previously, he worked as the Managing Director & Head-Technical Division at Fata Assicurazioni Danni SpA.
Keine Ergebnisse zu dieser Suche
- Börse
- Erweiterte Suche
- Luigi Lovaglio